A retrospective real-world study of disitamab vedotin combined with tislelizumab versus chemotherapy in patients with previously untreated metastatic urothelial carcinoma.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Han Se, Xiaomeng Gui, Lin Wang, Jing Jing, Riguleng Si, Haojing Li, Dongchen Lv, Jia Li, Ning Chi, Sanxiang Li, Hong Yang
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407700375
